Madrigal Pharmaceuticals valuation

MDGL · NASDAQ · USD

Compare Madrigal Pharmaceuticals
$421.99Change from previous close: −0.46%Absolute change: −$1.97

Close · November 17, 2026

Valuation

The average price target of 18 analysts is $688.78.

Data as of November 16, 2026

Madrigal Pharmaceuticals compared with similar companies

Madrigal Pharmaceuticals's Forward P/E: 38.1, +143% against the median of a group of 7 similar companies (15.7).

Madrigal Pharmaceuticals's metrics compared with similar companies
MetricMadrigal PharmaceuticalsMedian25th–75th percentileBand
Forward P/E38.115.79.12 – 24.0High
Price/book15.815.75.28 – 18.1Middle
Price/sales6.958.416.66 – 15.9Middle
Gross margin91.0%91.0%59.7% – 95.3%Middle
Operating margin-10.7%0.8%-19.7% – 24.5%Middle
Net margin-10.9%0.0%-5.7% – 10.3%Low
ROE-24.8%8.2%-9.7% – 38.5%Low
Debt/equity0.560.120.02 – 0.62Middle

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

Other metrics

Valuation multiples

Market cap
$9.93B
Enterprise value
$9.32B
P/E (trailing 12 months)
-30.1
EV/EBITDA
-61.7
EV/revenue
6.53

Profitability and growth

ROA
-6.8%
ROIC
-23.8%
Revenue growth (year over year)
50.1%
Earnings growth (year over year)
31.9%

Financial health

Total cash
$960.97M
Total debt
$354.22M
Current ratio
3.05
Quick ratio
2.62
Altman Z-Score
7.92
Piotroski F-Score
1.00

Dividends

Dividend yield
0.0%
Payout ratio
0.0%

Analysts and estimates

Average price target
$688.78
Median price target
$660.00
High price target
$962.00
Low price target
$479.00
Analysts with a price target
18
Consensus
Strong buy
Forward EPS
$11.21
EPS estimate, current year
-$2.00

Shares and trading

Beta
-1.00
Average volume
355.87K
Shares outstanding
23.23M
Float
13.96M
Institutional ownership
104.7%
Insider ownership
6.4%
Short interest (% of float)
10.8%
Short ratio (days)
7.25